These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 33213353)

  • 1. In silico Screening of Pyridoxine Carbamates for Anti-Alzheimer's Activities.
    Baswar D; Sharma A; Mishra A
    Cent Nerv Syst Agents Med Chem; 2021; 21(1):39-52. PubMed ID: 33213353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. De-novo Drug Design, Molecular Docking and In-Silico Molecular Prediction of AChEI Analogues through CADD Approaches as Anti-Alzheimer's Agents.
    Pandey S; Singh BK
    Curr Comput Aided Drug Des; 2020; 16(1):54-72. PubMed ID: 30827255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular docking and molecular dynamics approach to identify potential compounds in
    Tung BT; Hang TTT; Kim NB; Nhung NH; Linh VK; Thu DK
    J Complement Integr Med; 2022 Dec; 19(4):955-965. PubMed ID: 35621378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In silico Structure-based Identification of Novel Acetylcholinesterase Inhibitors Against Alzheimer's Disease.
    Iman K; Mirza MU; Mazhar N; Vanmeert M; Irshad I; Kamal MA
    CNS Neurol Disord Drug Targets; 2018 Apr; 17(1):54-68. PubMed ID: 29336270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of Anti-Alzheimer's Activity of Flavonoids Targeting Acetylcholinesterase in silico.
    Das S; Laskar MA; Sarker SD; Choudhury MD; Choudhury PR; Mitra A; Jamil S; Lathiff SMA; Abdullah SA; Basar N; Nahar L; Talukdar AD
    Phytochem Anal; 2017 Jul; 28(4):324-331. PubMed ID: 28168765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of new phenyl sulfonyl-pyrimidine carboxylate derivatives as the potential multi-target drugs with effective anti-Alzheimer's action: Design, synthesis, crystal structure and in-vitro biological evaluation.
    Manzoor S; Prajapati SK; Majumdar S; Raza MK; Gabr MT; Kumar S; Pal K; Rashid H; Kumar S; Krishnamurthy S; Hoda N
    Eur J Med Chem; 2021 Apr; 215():113224. PubMed ID: 33582578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacophore mapping-based virtual screening followed by molecular docking studies in search of potential acetylcholinesterase inhibitors as anti-Alzheimer's agents.
    Ambure P; Kar S; Roy K
    Biosystems; 2014 Feb; 116():10-20. PubMed ID: 24325852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 2D-QSAR, molecular docking and MD simulation based virtual screening of the herbal molecules against Alzheimer's disorder: an approach to predict CNS activity.
    Thakur A; Sharma B; Parashar A; Sharma V; Kumar A; Mehta V
    J Biomol Struct Dyn; 2024; 42(1):148-162. PubMed ID: 36970779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Designing Second Generation Anti-Alzheimer Compounds as Inhibitors of Human Acetylcholinesterase: Computational Screening of Synthetic Molecules and Dietary Phytochemicals.
    Amat-Ur-Rasool H; Ahmed M
    PLoS One; 2015; 10(9):e0136509. PubMed ID: 26325402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identifying natural compounds as multi-target-directed ligands against Alzheimer's disease: an in silico approach.
    Ambure P; Bhat J; Puzyn T; Roy K
    J Biomol Struct Dyn; 2019 Mar; 37(5):1282-1306. PubMed ID: 29578387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening and identification of secondary metabolites in the bark of
    Khare N; Maheshwari SK; Jha AK
    J Biomol Struct Dyn; 2021 Oct; 39(16):5988-5998. PubMed ID: 32720564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lead Identification Through
    Agarwal D; Kumar S; Ambatwar R; Bhanwala N; Chandrakar L; Khatik GL
    Cent Nerv Syst Agents Med Chem; 2024; 24(2):219-242. PubMed ID: 38288823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A single-molecule with multiple investigations: Synthesis, characterization, computational methods, inhibitory activity against Alzheimer's disease, toxicity, and ADME studies.
    Şahin S
    Comput Biol Med; 2022 Jul; 146():105514. PubMed ID: 35462270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-alkylpiperidine carbamates as potential anti-Alzheimer's agents.
    Košak U; Strašek N; Knez D; Jukič M; Žakelj S; Zahirović A; Pišlar A; Brazzolotto X; Nachon F; Kos J; Gobec S
    Eur J Med Chem; 2020 Jul; 197():112282. PubMed ID: 32380361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel Substituted Pyrimidine Derivatives as Potential Anti-Alzheimer's Agents: Synthesis, Biological, and Molecular Docking Studies.
    Pant S; Kumar K R; Rana P; Anthwal T; Ali SM; Gupta M; Chauhan M; Nain S
    ACS Chem Neurosci; 2024 Feb; 15(4):783-797. PubMed ID: 38320262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combining in silico and in vitro approaches to evaluate the acetylcholinesterase inhibitory profile of some commercially available flavonoids in the management of Alzheimer's disease.
    Kuppusamy A; Arumugam M; George S
    Int J Biol Macromol; 2017 Feb; 95():199-203. PubMed ID: 27871793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding interactions and in silico ADME prediction of isoconessimine derivatives as potent acetylcholinesterase inhibitors.
    Tue-Ngeun P; Rakitikul W; Thinkumrob N; Hannongbua S; Meelua W; Jitonnom J
    J Mol Graph Model; 2024 Jun; 129():108746. PubMed ID: 38401250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination of Memantine and 6-Chlorotacrine as Novel Multi-Target Compound against Alzheimer's Disease.
    Kaniakova M; Nepovimova E; Kleteckova L; Skrenkova K; Holubova K; Chrienova Z; Hepnarova V; Kucera T; Kobrlova T; Vales K; Korabecny J; Soukup O; Horak M
    Curr Alzheimer Res; 2019; 16(9):821-833. PubMed ID: 30819076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In silico screening of glycogen synthase kinase-3β targeted ligands against acetylcholinesterase and its probable relevance to Alzheimer's disease.
    Jabir NR; Shakil S; Tabrez S; Khan MS; Rehman MT; Ahmed BA
    J Biomol Struct Dyn; 2021 Sep; 39(14):5083-5092. PubMed ID: 32588759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular docking and receptor-specific 3D-QSAR studies of acetylcholinesterase inhibitors.
    Deb PK; Sharma A; Piplani P; Akkinepally RR
    Mol Divers; 2012 Nov; 16(4):803-23. PubMed ID: 22996404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.